Removing fallopian tubes, a procedure known as opportunistic salpingectomy, may help prevent the development of ovarian cancer, according to a consensus statement from the Ovarian Cancer Research ...

NICE has recommended mirvetuximab soravtansine for resistant ovarian cancer, citing better survival and a less burdensome treatment experience.

Removing fallopian tubes, a procedure known as opportunistic salpingectomy, may help reduce the risk of developing ovarian cancer, according to a consensus statement from the Ovarian Cancer Research ...

The most effective step to battling ovarian cancer may have little to do with ovaries and more to do with surgical removal of the fallopian tubes. In this procedure, called a salpingectomy, the tubes ...

A groundbreaking drug, Elahere, has been approved in the UK, offering new hope for women with advanced ovarian cancer ...

Because there is no effective screening method to catch ovarian cancer at an early stage, most diagnoses occur when the cancer has reached its later stages. As a result, only about half of women with ...

On average, it can extend lives from 12.8 months on chemotherapy to 16.5 months on the therapy, and has fewer side-effects.

Ovarian cancer is a relatively rare disease that mainly affects older women. However, it is also a condition that is challenging to diagnose early on. Very often, by the time a person experiences ...

Stem cell scientists at Cedars-Sinai Medical Center have revealed the origins of a common type of ovarian cancer by modeling fallopian tube tissues. Studies using the fallopian tube organoids allowed ...

A mathematical modeling study conducted in Germany suggests that ovarian cancer incidence could be reduced and health care savings boosted if women who have already completed their families were ...

Women taking the drug tell the BBC it has given them their lives back.

Ovarian cancer occurs when there is an uncontrolled growth of abnormal cells in the ovaries or fallopian tubes. This is one ...